Late-breaking Data Highlights Super-responders to Delgocitinib Cream for CHE
Leo Pharma’s delgocitinib cream produces a deep, consistent, and/or maintained response in a subgroup of super-responders with moderate-to-severe Chronic Hand Eczema (CHE), according to a late-breaker presented at the American Academy of Dermatology’s 2025 Annual Meeting in Orlando, FL. The subgroup analysis was based on the treatment response in patients with moderate-to-severe CHE treated with […]